Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
16 April 2021 - preview of changes for May 2021
|
Pharmaceutical |
Change |
|---|---|
|
Adalimumab inj 20 mg per 0.4 ml syringe and 40 mg per 0.8 ml syringe (Humira) and 40 mg per 0.8 ml pen (HumiraPen) |
amended restriction criteria |
|
Arginine tab 100 mg and cap 500 mg |
new listing |
|
Bendamustine hydrochloride (Ribomustin) inj 25 mg and 100 mg vial |
addition of new restriction criteria |
|
Bupivacaine hydrochloride with and fentanyl (Bupafen NRFit) inj 1.25 mg with fentanyl 2 mcg per ml, 15 ml syringe |
new listing (p’code 2594196) |
|
Carglumic acid tab disp 200 mg |
new listing |
|
Clonazepam (Rivotril) inj 1 mg per ml, 1 ml ampoule |
to be delisted 1 October 2021 |
|
Coenzyme Q10 cap 120 mg and 160 mg |
new listing |
|
Escitalopram tab 10 mg and 20 mg |
Brand change Escitalopram (Ethics) – new listing and addition of HSS
Escitalopram-Apotex to be delisted 1 October 2021 |
|
Etanercept (Enrel) inj 25 mg autoinjector, 25 mg vial, 50 mg autoinjector, 50 mg syringe |
amended restriction criteria |
|
Fluconazole inj 2 mg per ml, 100 ml vial |
Brand change
|
|
Hypromellose (Methopt) eye drops 0.5 %, 15 ml |
increase price |
|
Infliximab (Remicade) inj 100 mg |
amended restriction criteria |
|
Ketamine (Ketamine-Baxter) inj 100 mg per ml, 2 ml ampoule |
to be delisted 1 September 2021 |
|
Lenalidomide (Revlimid) cap 5 mg, 10 mg, 15 mg and 25 mg |
amended restriction criteria |
|
Levocarnitine tab 500 mg, cap 250 mg and oral liquid 500 mg per 10 ml |
new listing |
|
Mixed salt solution for eye irrigation (e.g. Balanced Salt Solution) eye irrigation solution calcium chloride 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium citrate 0.17%, 500 ml bag |
new listing |
|
Norethisterone (Primolut N) tab 5 mg |
Pack size change
|
|
Omeprazole tab dispersible 10 mg |
new listing |
|
Riboflavin tab 100 mg and cap 100 mg |
new listing |
|
Secukinumab (Cosentyx) inj 150 mg per ml, 1 ml prefilled syringe |
|
|
Sodium cromoglicate aerosol inhaler 5 mcg per dose |
delisting delayed until 1 November 2021 |
|
Taurine cap 1,000 mg and powder |
new listing |
|
Terazosin (Apo-Terazosin) tab 2 mg and 5 mg |
to be delisted 1 August 2021 |